This issue covers the story of a young vibrant personality who raised to success and fame in the healthcare sector, the space which is largely dominated by the male peers. As she ventured into the entrepreneurial road, she not only grabbed the investor’s trust but became media’s favourite. Attaining the feat of being a billionaire before turning 30 was after all a no minor feat! But the fairytale rise of Elizabeth Holmes’ Theranos soon came to a horrendous fall. Find out the truth behind its speculated fraud, revoking its California lab license and banning the charming young entrepreneur from the business for at least two years in this issue. Other articles to interest are “The DeepMind controversy- is patient data at risk”, article on “AI, Robotics and Biotech” , “Ebola sets for a scathing re-entry”, “Turning waste into wealth” and more. Our utmost gratitude to Mr. Vijay G. Pande, Managing Director, Vijyoti and Mr. R.P Mishra, Director, Innovation LifeSciences for sparing their precious time and interacting with Biotecnika magazine.
About BioTecNika Magazine:
Biotecnika Info Labs Pvt Ltd, (established in 2006) located in Bangalore and Noida (India), is a bio-science information portal lead by a group of biotechnologists, efforting to minimize the extant gap between industry and the personnel associated with bio-science.
Biotecnika Magazine, founded in the year 2013, is one of the India’s largest growing magazine which serves as an essential guide to a plethora of audience fromindustry and academia. Distinguished by its in-depth analysis and latest information, magazine showcases its features that are insightful, informative and presented with style. The list does not stop as we also bring to you the country’s first web TV broadcasting various events, interviews and programs to interest our readers.
Biotecnika magazine being interpreted as a “Mirror to Biotechnology Industry”, delivers the best of bioscience world to its audience from every vertical. Constantly striving to be the leading life science magazine in the country, we yearn to be an insight into the bioscience sector and uphold “Business to Business” and “Business to Consumer” relationship.
Currently with a response involving more than 9, 25,000 ( Online), the ardor to serve you better has only amplified.